 On Wednesday, HC WainWright began coverage of Field Trip Health NASDAQ:FTRP, a company in the psychedelics space, which is developing a chain of psychedelics-assisted therapy clinics throughout North America and Europe. The firm gave Field Trip a Buy rating and a 20 price target, pushing the companys shares from 4.5 on Tuesday at market close to 5.3 on Wednesday morning. 